Global Adult Vaccines Market Insights, Forecast to 2025

Description

The global Adult Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Adult Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Adult Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Adult Vaccines in these regions.
This research report categorizes the global Adult Vaccines market by top players/brands, region, type and end user. This report also studies the global Adult Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Sanofi Pasteur
Merck
Novartis
Pfizer
BioCSL (Seqirus)
Protein Sciences

Market size by Product
Influenza
Cervical Cancer
Zoster Shingles
Pneumococcal
Meningococcal
MMRV
Hepatitis
DTP
Travel and Miscellaneous
Market size by End User
Medical Care
Healthy
Hospita

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Adult Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Adult Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Adult Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Adult Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Adult Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Adult Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Study Coverage
1.1 Adult Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Adult Vaccines Market Size Growth Rate by Product
1.4.2 Influenza
1.4.3 Cervical Cancer
1.4.4 Zoster Shingles
1.4.5 Pneumococcal
1.4.6 Meningococcal
1.4.7 MMRV
1.4.8 Hepatitis
1.4.9 DTP
1.4.10 Travel and Miscellaneous
1.5 Market by End User
1.5.1 Global Adult Vaccines Market Size Growth Rate by End User
1.5.2 Medical Care
1.5.3 Healthy
1.5.4 Hospita
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Adult Vaccines Market Size
2.1.1 Global Adult Vaccines Revenue 2014-2025
2.1.2 Global Adult Vaccines Sales 2014-2025
2.2 Adult Vaccines Growth Rate by Regions
2.2.1 Global Adult Vaccines Sales by Regions
2.2.2 Global Adult Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Adult Vaccines Sales by Manufacturers
3.1.1 Adult Vaccines Sales by Manufacturers
3.1.2 Adult Vaccines Sales Market Share by Manufacturers
3.1.3 Global Adult Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Adult Vaccines Revenue by Manufacturers
3.2.1 Adult Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Adult Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Adult Vaccines Price by Manufacturers
3.4 Adult Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Adult Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Adult Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Adult Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Adult Vaccines Sales by Product
4.2 Global Adult Vaccines Revenue by Product
4.3 Adult Vaccines Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Adult Vaccines Breakdown Data by End User

6 North America
6.1 North America Adult Vaccines by Countries
6.1.1 North America Adult Vaccines Sales by Countries
6.1.2 North America Adult Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Adult Vaccines by Product
6.3 North America Adult Vaccines by End User

7 Europe
7.1 Europe Adult Vaccines by Countries
7.1.1 Europe Adult Vaccines Sales by Countries
7.1.2 Europe Adult Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Adult Vaccines by Product
7.3 Europe Adult Vaccines by End User

8 Asia Pacific
8.1 Asia Pacific Adult Vaccines by Countries
8.1.1 Asia Pacific Adult Vaccines Sales by Countries
8.1.2 Asia Pacific Adult Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Adult Vaccines by Product
8.3 Asia Pacific Adult Vaccines by End User

9 Central & South America
9.1 Central & South America Adult Vaccines by Countries
9.1.1 Central & South America Adult Vaccines Sales by Countries
9.1.2 Central & South America Adult Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Adult Vaccines by Product
9.3 Central & South America Adult Vaccines by End User

10 Middle East and Africa
10.1 Middle East and Africa Adult Vaccines by Countries
10.1.1 Middle East and Africa Adult Vaccines Sales by Countries
10.1.2 Middle East and Africa Adult Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Adult Vaccines by Product
10.3 Middle East and Africa Adult Vaccines by End User

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline Adult Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GlaxoSmithKline Adult Vaccines Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Pasteur Adult Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Pasteur Adult Vaccines Products Offered
11.2.5 Sanofi Pasteur Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Adult Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Adult Vaccines Products Offered
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Adult Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Adult Vaccines Products Offered
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Adult Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Adult Vaccines Products Offered
11.5.5 Pfizer Recent Development
11.6 BioCSL (Seqirus)
11.6.1 BioCSL (Seqirus) Company Details
11.6.2 Company Business Overview
11.6.3 BioCSL (Seqirus) Adult Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 BioCSL (Seqirus) Adult Vaccines Products Offered
11.6.5 BioCSL (Seqirus) Recent Development
11.7 Protein Sciences
11.7.1 Protein Sciences Company Details
11.7.2 Company Business Overview
11.7.3 Protein Sciences Adult Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Protein Sciences Adult Vaccines Products Offered
11.7.5 Protein Sciences Recent Development

12 Future Forecast
12.1 Adult Vaccines Market Forecast by Regions
12.1.1 Global Adult Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Adult Vaccines Revenue Forecast by Regions 2019-2025
12.2 Adult Vaccines Market Forecast by Product
12.2.1 Global Adult Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Adult Vaccines Revenue Forecast by Product 2019-2025
12.3 Adult Vaccines Market Forecast by End User
12.4 North America Adult Vaccines Forecast
12.5 Europe Adult Vaccines Forecast
12.6 Asia Pacific Adult Vaccines Forecast
12.7 Central & South America Adult Vaccines Forecast
12.8 Middle East and Africa Adult Vaccines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Adult Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry